JD.com Grows Fastest Since 2022 After Advancing Against Meituan
(Bloomberg) -- JD.com Inc.'s revenue grew at its fastest pace in three years after stimulus measures from Beijing and an aggressive drive to compete with Meituan in food delivery helped revitalize consumer spending.
A New Central Park Amenity, Tailored to Its East Harlem Neighbors
What's Behind the Rise in Serious Injuries on New York City's Streets?
NYC Warns of 17% Drop in Foreign Tourists Due to Trump Policies
LA Mayor Credits Trump on Fire Aid, Stays Wary on Immigration
Lawsuit Challenges Trump Administration Policy on Migrant Children
Its shares swung between gains and losses in pre-market US trading after the company reported a 16% rise in sales to 301.1 billion yuan ($42 billion) for the March quarter. JD is now handling close to 20 million food orders daily, executives said Tuesday, surging from just a month ago and already about a fifth of Meituan's 2024 peak of about 98 million.
That rapid expansion underscores concerns about JD's entry into a hyper-competitive — and low-margin — arena dominated by Meituan. Since joining the field this year, JD has introduced coupons to attract new users. In April, it vowed to recruit 100,000 full-time riders over three months.
Losses doubled in its new business segment in the quarter, reflecting that outlay. Still, improving consumer spending on big-ticket items such as electronics drove a 53% leap in overall net income. On Tuesday, China's market watchdog disclosed it had recently summoned executives from Meituan, JD and Alibaba Group Holding Ltd. to deliver a warning about unruly competition.
'Food delivery is a natural extension of our retail business,' Chief Executive Officer Sandy Xu told analysts, reiterating the company's stance. 'China's food delivery market is big and has room for multiple platforms.'
JD's overall business has held up well despite growing concerns about the fallout from global trade tensions on a rickety Chinese economy.
Beijing this year has doled out purchase or trade-in subsidies on products from appliances to smartphones and cars, aiming to revitalize anemic consumption.
The subsidies, which began last year, have proven popular with belt-tightening consumers looking for bargains. In May, policymakers announced a slew of new stimulus measures including monetary policy easing, seeking to counter the potential fallout from a global trade war. Progress in trade talks between Beijing and Washington could also ease some of the pressure.
What Bloomberg Intelligence Says
JD.com's narrower 1Q adjusted operating profit beat vs. consensus estimates for retail and new businesses, which exceeded projections by 17%, down from 18% in the prior four quarters, heightens the risk that the firm will struggle to deliver stronger-than-expected earnings of the same magnitude as it spends more to expand into food delivery and grab share from incumbents. Such expenditures already doubled 1Q losses from new businesses vs. a year earlier to surpass 37% of market estimates.
- Catherine Lim and Trini Tan, analysts
Click here for the research.
Net income jumped to 10.9 billion yuan in the first quarter. That's even as losses from new initiatives soared to 1.3 billion yuan from just 670 million yuan a year ago.
Investors have called JD's investment into food delivery 'unsustainable,' and worried that the battle with Meituan will hurt earnings — long a focus for a company accustomed to competing with aggressive rivals such as PDD Holdings Inc. and Alibaba.
JPMorgan Chase & Co. estimated that, at the current scale, the business could generate up to 18 billion yuan in annualized losses, wiping out 36% of its parent's operating profit for 2025.
--With assistance from Charlotte Yang and Vlad Savov.
The Recession Chatter Is Getting Louder. Watch These Metrics
US Border Towns Are Being Ravaged by Canada's Furious Boycott
Two Million Meat Sticks a Day Isn't Enough for Chomps' CEO
Maybe AI Slop Is Killing the Internet, After All
With the New York Liberty, Clara Wu Tsai Aims for the First $1 Billion Women's Sports Franchise
©2025 Bloomberg L.P.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Trump admin. cancels Moderna bird fu vaccine contract
The Trump administration has canceled a contract with Moderna (MRNA) worth hundreds of millions of dollars. The contract was supposed to help Moderna develop a vaccine for humans to defend against bird flu. Yahoo Finance Senior Health Care Reporter Anjalee Khemlani reports the details in the video above. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Trump administration canceling more than $700 million awarded to drug maker Moderna to develop the vaccine against potential pandemic viruses. For more we're bringing in here Yahoo Finance Senior Health Reporter, Angeli Kamani. Ange. Yeah, like you mentioned, the NIH canceled more than $750, a million dollars, rather, in funding for Moderna. And this is something that the company found out just based on a notification to themselves, even though they were really expecting that to get into late stage development. They said in a statement, Moderna received notice that the Health and Human Services Department, remember led by Secretary Robert F. Kennedy will terminate the award for the late stage development and rights to purchase the pre-pandemic influenza vaccines. Now, we went out to HHS to understand what their rationale was behind this. And among other things they mentioned that the MRNA technology remains quote, "under tested" and we are not going to spend taxpayer dollars repeating the mistakes of the last administration which concealed legitimate safety concerns from the public. And in that they're referring to the myocarditis that was evident in some males and some younger individuals. So, this is really just the latest setback for the company. We know it's been pummeled, the stock is down more than 30% on the year. This is one of the latest. So, we know that they pulled their filing of a combination flu and COVID vaccine earlier last week. Then we've got the NIH funding that's cutting the pandemic and bird flu. And then we've also got missing the Q1 estimates earlier this year. So, just really telling a really hard story for this company. We know it's been under pressure because of the waning COVID revenues, and these are just some of those areas that were supposed to sort of plug that hole. And now, without those in the way, it's a question on what Moderna's viability is. Now, on the flip side, you do have some good news, right? The company's still working on a number of clinical trials with Merck on cancer vaccine. It also has a partnership with Vertex on cystic fibrosis. So, they do have a few other things going for them, but this is really a longer play for the company rather than any near term that they would have otherwise been able to take advantage of. All right. Thanks, Angeli. Appreciate it. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Elon Musk Slams Trump's Spending Bill: ‘A Disgusting Abomination'
A serious rift has erupted between Elon Musk and President Trump over the massive government spending bill the president has urged Congress to pass. Musk, who donated nearly $275 million toward Trump's 2024 election campaign, on Tuesday posted on X an unambiguous denunciation of the bill, which is called the One Big, Beautiful Bill Act. More from Variety London Mayor Sadiq Khan Hails 'Adolescence' for Having 'Mainstreamed' Conversation About 'Epidemic' of Violence Against Women Jon Stewart Tackles Elon Musk's Exit From the Trump Administration: 'This Guy Has Seen Some S--' Elon Musk Says New York Times Is 'Lying Their Ass Off' About His Alleged Drug Use; Newspaper Defends Coverage 'I'm sorry, but I just can't stand it anymore. This massive, outrageous, pork-filled Congressional spending bill is a disgusting abomination,' Musk wrote. 'Shame on those who voted for it: you know you did wrong. You know it.' The tech mogul wrote that the bill 'will massively increase the already gigantic budget deficit' and that 'Congress is making America bankrupt.' Musk, the world's richest person, also posted a warning that voters would 'fire all politicians who betrayed the American people' in the 2026 midterm elections. On May 28, Musk announced the he would end his tenure as a 'special government employee' — leading the White House's Department of Government Efficiency, or DOGE — after 128 days. Per the U.S. Department of the Interior, a person cannot serve in such a role for more than 130 days in a consecutive year. Sen. Ran Paul (R-Kentucky) was among those chiming in to agree with Musk. 'We have both seen the massive waste in government spending and we know another $5 trillion in debt is a huge mistake. We can and must do better,' he wrote, quoting Musk's post. Trump, on Truth Social, earlier in the day slammed Paul, writing 'Rand Paul has very little understanding of the BBB, especially the tremendous GROWTH that is coming. He loves voting 'NO' on everything, he thinks it's good politics, but it's not. The BBB is a big WINNER!!!' At a White House press briefing, Fox News correspondent Peter Doocy asked press secretary Karoline Leavitt 'how mad do you think President Trump is going to be' about Musk's comments? Leavitt responded that Trump 'already knows where Elon Musk stood on this bill. It doesn't change the president's opinion. This is one big, beautiful bill, and he's sticking to it.' The One Big, Beautiful Bill Act passed the Republican-controlled House but has yet to clear the Senate. The legislation would make Trump's 2017 tax cuts permanent (with wealthy Americans benefiting the most) and increase funding for the U.S. military and immigration enforcement. In addition, the version that passed the House cuts funding for health, nutrition, education and clean energy programs. Musk has criticized the 'Big Beautiful Bill' before, but using tamer terminology. Last week, for example, Musk criticized Trump's 'massive spending bill' in an interview with CBS's 'Sunday Morning,' saying the legislation 'undermines the work' of DOGE. Best of Variety What's Coming to Netflix in June 2025 New Movies Out Now in Theaters: What to See This Week 'Harry Potter' TV Show Cast Guide: Who's Who in Hogwarts?
Chicago Tribune
24 minutes ago
- Chicago Tribune
Column: Court says Trump tariffs are presidential overreach
The Trump administration's arbitrary moves to restructure the international trade environment to accommodate White House whims have suddenly run into reality, specifically established laws. This confrontation is still in the early stages, but it does not bode well for President Donald Trump and his ardent protectionist associates. On May 28, the U.S. Court of International Trade went back to basics in a decision featuring the reminder that, under the Constitution, Congress has the authority to regulate trade. This fundamental power is not overridden by the ability of the president to address trade challenges in an emergency. 'The court does not pass upon the wisdom or likely effectiveness of the President's use of tariffs as leverage,' a three-judge panel said in the decision to issue a permanent injunction on the blanket tariff orders issued by Trump since January. 'That use is impermissible not because it is unwise or ineffective, but because [federal law] does not allow it.' The ruling came in response to two lawsuits. One was filed by the Liberty Justice Center, a nonpartisan organization, on behalf of five small U.S. companies that import goods from countries targeted by Trump's tariffs. The other was filed by a dozen state governments within the U.S. Oregon Attorney General Dan Rayfield, a Democrat, is coordinating the states' efforts against the administration. He has declared the tariffs to be economically devastating, reckless and unlawful. Small businesses seeking relief include an importer of wine and other alcoholic beverages based in New York and a maker of educational kits and musical instruments located in Virginia. President Trump has been basing his unilateral tariff authority on the International Economic Emergency Powers Act (IEEPA), passed by Congress and signed into law by President Jimmy Carter near the end of December 1977. The law authorizes the president to declare 'an unusual and extraordinary threat to the national security, foreign policy, or economy of the United States,' with the proviso that such threats must originate, 'in whole or substantial part outside the United States,' and requires the president to provide updates to Congress every six months. An incentive for this legislation was a desire in Congress to clarify and restrict presidential actions justified under the 1917 Trading With the Enemy Act, a law which reflected the emergency leading to U.S. entry into World War I as a formal declared combatant. The immediate incentive for our nation to enter that war was the declaration by Germany of unrestricted submarine warfare. The 1917 law had been used to justify a variety of presidential initiatives, not all related to foreign policy and international developments. Declared national emergencies then still technically in effect included the 1933 banking crisis related to the hoarding of cash and gold, the 1950 Korean War crisis, a 1970 emergency related to a strike by postal workers and a 1971 emergency related to the deteriorating fiscal condition of the federal government. Key powers granted include the ability to block transactions and take control of the assets of the parties involved in the threats. This section was used by the Trump administration to justify the new tariffs. IEEPA was passed during a time of congressional assertiveness. Another important factor, no doubt, was President Carter's fixation on clear, orderly administration, which he carried to extremes. The severe national crises, traumas and wars described above contrast with today's long-term growth and prosperity, and blessed absence of direct involvement in war. The judicial veto of presidential overreach shows our system is working.
